Document Detail


Differences in glucose tolerance between deficit and nondeficit schizophrenia.
MedLine Citation:
PMID:  19046857     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Some studies suggest that schizophrenia is associated with an increased risk of diabetes independently of antipsychotic use. People with deficit schizophrenia, which is characterized by primary (or idiopathic), enduring negative symptoms, differ from those with nondeficit schizophrenia on course of illness, treatment response, risk factors, and biological correlates. We hypothesized that deficit and nondeficit subjects would also differ with regard to glucose tolerance. Newly diagnosed, antipsychotic-naïve subjects with nonaffective psychosis and matched control subjects were administered a 75 g oral glucose tolerance test (GTT). Two-hour glucose concentrations were significantly higher in the nondeficit patients (N=23; mean [SD] of 121.6 [42.0]) than in deficit (N=23; 100.2 [23.1]) and control subjects (N=59; 83.8 [21.9]); the deficit subjects also had significantly higher two-hour glucose concentrations than did the control subjects. These results provide further support that the deficit group has a distinctive etiopathophysiology.
Authors:
Brian Kirkpatrick; Emilio Fernandez-Egea; Clemente Garcia-Rizo; Miguel Bernardo
Related Documents :
15757127 - Evaluation of glucose metabolism in three horses with lower motor neuron degeneration.
6989547 - Effects of amiloride on oral glucose loading, serum potassium, renin, and aldosterone i...
8739917 - Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, ...
2280237 - Antihypertensive drugs and glucose metabolism: comparison between a diuretic, a beta-bl...
11078457 - Effects of differing durations of antecedent hypoglycemia on counterregulatory response...
19349317 - High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2008-11-28
Journal Detail:
Title:  Schizophrenia research     Volume:  107     ISSN:  0920-9964     ISO Abbreviation:  Schizophr. Res.     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-01-23     Completed Date:  2009-04-20     Revised Date:  2011-09-26    
Medline Journal Info:
Nlm Unique ID:  8804207     Medline TA:  Schizophr Res     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  122-7     Citation Subset:  IM    
Affiliation:
Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta, Georgia 30912, USA. bkirkpatrick2@aol.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Affective Symptoms / blood*,  diagnosis,  genetics,  psychology
Body Mass Index
Case-Control Studies
Diabetes Mellitus, Type 2 / blood,  diagnosis,  genetics,  psychology
Female
Genetic Predisposition to Disease / genetics
Glucose Tolerance Test*
Humans
Male
Psychiatric Status Rating Scales
Risk Factors
Schizophrenia / blood*,  diagnosis,  genetics
Schizophrenic Psychology*
Young Adult
Grant Support
ID/Acronym/Agency:
R01 DK069265/DK/NIDDK NIH HHS; R01 DK069265-04/DK/NIDDK NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of cognitive behavioral therapy on work outcomes in vocational rehabilitation for participan...
Next Document:  The prevalence and correlates of hallucinations in Australian adolescents: results from a national s...